HeartFlow
PublicHeartFlow is now publicly traded
The data on this page reflects HeartFlow's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Aug 8, 2025
Last Round
Convertible Debt
Mar 26, 2025
Total Funding Raised
$1.11B
Company Overview
HeartFlow operates in Healthcare/Wellness and is based in Mountain View, California. Its recorded funding history includes a Convertible Debt round in March 2025.
HeartFlow is a healthcare technology company that provides AI-powered cardiac diagnostic software to assess coronary artery disease by creating personalized 3D models of arteries from CT scans.
Sector
Healthcare/Wellness
Verticals
HealthTech, Life Sciences, TMT
AI Layer
Application
HeartFlow Comparables
Compare HeartFlow with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cleerly | 84% | |
| Artrya Ltd | 82% | |
| CathWorks | 82% |
For institutional investors. Book with your work email.
HeartFlow Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Aug 8, 2025 | ||||
| Convertible Debt | Mar 26, 2025 | ||||
| Series F | Apr 6, 2023 | ||||
| Series E Extension | Jun 14, 2019 | ||||
| Series E | Feb 14, 2018 | ||||
Series D | May 20, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HeartFlow Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Convertible Debt, Series F |
| Janus Henderson Group | Convertible Debt, Series F |
| HealthCor Partners Management | Series F, Series D |
| Capricorn Investment Group | Series F, Series D, Convertible Debt |
| Martis Capital Management | Series F |
| Fidelity Management & Research Company | Convertible Debt |
| Hayfin Capital Management | Series F, Series D |
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueNov 13, 2026
HeartFlow, Inc. raises its 2026 full-year revenue forecast to $246M to $250M, representing 40% to 42% year-over-year growth.
- has_revenue_increased_byNov 13, 2026
HeartFlow, Inc. reports third-quarter revenue rising 57% to $72.9 million in Q3 '26.
- files_suit_againstOct 26, 2026
In Apr '26, HeartFlow, Inc. sues Denver-based Cleerly LLC for allegedly infringing six patents while developing AI-powered coronary CT angiography evaluation technologies.
- files_suit_againstOct 26, 2026
On Oct 22nd '26, HeartFlow, Inc. files a lawsuit against Elucid, alleging patent infringement and trade secret misappropriation, and seeks a jury trial and damages.
- has_revenue_increased_bySep 15, 2026
HeartFlow, Inc. reports quarterly revenue of $64.08 million, up 47.7% year over year.
For institutional investors. Book with your work email.
HeartFlow Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.